Pre-transplant Soluble CD30 Is Associated With Bronchiolitis Obliterans Syndrome After Lung Transplantation
- 1 April 2006
- journal article
- lung rejection
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 25 (4) , 416-419
- https://doi.org/10.1016/j.healun.2005.07.018
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Bronchial hyperresponsiveness and the bronchiolitis obliterans syndrome after lung transplantationThe Journal of Heart and Lung Transplantation, 2005
- Heme oxygenase-1 expression in alveolar macrophages is elevated in patients with bronchiolitis obliterans syndrome after lung transplantationThe Journal of Heart and Lung Transplantation, 2004
- Bronchoalveolar lavage cytokine profile in a cohort of lung transplant recipients: A predictive role of interleukin-12 with respect to onset of bronchiolitis obliterans syndromeThe Journal of Heart and Lung Transplantation, 2004
- CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 responseTransplant Immunology, 2003
- Evaluation of posttransplantation soluble CD30 for diagnosis of acute renal allograft rejection1Transplantation, 2003
- Bronchiolitis Obliterans after Human Lung TransplantationAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Identification of Highly Responsive Kidney Transplant Recipients Using Pretransplant Soluble CD30Journal of the American Society of Nephrology, 2002
- CD30 and type 2 T helper (Th2) responsesJournal of Leukocyte Biology, 1995
- Preferential expression of CD30 by human CD4 + T cells producing Th2‐type cytokinesThe FASEB Journal, 1995
- Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's diseaseCell, 1992